Rhumbline Advisers Sanofi Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNY
# of Institutions
822Shares Held
268MCall Options Held
2MPut Options Held
1.9M-
Dodge & Cox San Francisco, CA76.3MShares$3.68 Billion2.67% of portfolio
-
Morgan Stanley New York, NY17.8MShares$857 Million0.08% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$644 Million0.32% of portfolio
-
Invesco Ltd. Atlanta, GA11.7MShares$562 Million0.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.6MShares$558 Million0.06% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $121B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...